Related Experiment Video
Updated: Mar 6, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
A Multidimensional Framework for Pharmaceutical Care to Enhance Medication Adherence and Patient Engagement: The
Ramón Morillo-Verdugo1, Olatz Ibarra-Barrueta2, Maria Teresa Martin Conde3
1Pharmacy Department, Virgen de Valme University Hospital, South Seville Health District, Seville, Spain.
Purpose:
This study aimed to develop Capacity-Motivation-Opportunity MAPEX (CMO-MAPEX), a multidimensional, patient-centred and operational framework to guide medication-adherence support in outpatient pharmaceutical care.
Methods:
A six-stage framework-development process was undertaken. First, a narrative scoping synthesis identified behavioural, experiential and organisational determinants of medication adherence relevant to outpatient pharmaceutical care. Second, key constructs were extracted and coded into a shared analytic matrix. Third, framework analysis was applied to cluster constructs into higher-order domains. Fourth, an integrative synthesis aligned the emergent CMO structure with evidence on adherence, treatment burden, patient experience and hybrid-care models. Fifth, the conceptual architecture was translated into a structured clinical workflow incorporating CMO-based assessment, a three-level complexity stratification system, domain-specific intervention families and hybrid follow-up rules. Finally, a multidisciplinary expert panel reviewed and refined the framework to ensure ecological validity and feasibility in routine practice.
Results:
The analysis yielded a stable three-domain structure-Capacity, Motivation and Opportunity-capturing patients' ability to manage treatment, their beliefs and emotional readiness, and the contextual conditions enabling or hindering adherence. These domains were operationalised through assessment indicators, complexity-based stratification, targeted intervention mapping and longitudinal hybrid-care pathways. Patient-reported outcome and experience measures were embedded as core components to monitor treatment burden, preferences and experience, and to support dynamic re-stratification and adjustment of follow-up intensity over time.
Conclusion:
CMO-MAPEX provides a pragmatic and scalable framework that translates adherence theory into patient-centred pharmaceutical care. By integrating behavioural determinants, patient experience and hybrid-care organisation within a single operational structure, it offers a reproducible approach to tailoring adherence support according to patient preferences and complexity in outpatient settings.
Related Concept Videos
Drug Therapy
Antianxiety Medications
Drug Dosing: Geriatric Patients
Oral Drug Delivery Systems: Continuous-Release Systems
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...
Patient-centered Care
Therapeutic Drug Monitoring: Affecting Factors
